Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This work was supported by bioMérieux. The Parasitology-Mycology Laboratory of Grenoble University Hospital Centre received research grants from Roche®, Abbott® and bioMérieux®.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Soltis RD, Hasz D, Morris MJ, Wilson ID. The effect of heat inactivation on aggregation of immunoglobulines. Immunology 1979;36:37–45.Search in Google Scholar
2. Tate J, Ward G. Interferences in immunoassay. Clin Biochem Rev 2004;25:105–20.Search in Google Scholar PubMed
3. Goldie DJ, McConnell AA, Cooke PR. Heat treatment of whole blood and serum before chemical analysis. Lancet 1985;1:1161.10.1016/S0140-6736(85)92466-3Search in Google Scholar PubMed
4. Gleeson M, Herd L, Burns C. Effect of heat inactivation of HIV on specific serum proteins and tumor markers. Ann Clin Biochem 1990;27:592–4.10.1177/000456329002700611Search in Google Scholar PubMed
5. Jungkind DJ, Direnzo SA, Young SJ. Effect of using heat-inactivated serum with the Abbott human T-Cell lymphotropic virus type III antibody test. J Clin Microbiol 1986;23:381–2.10.1128/jcm.23.2.381-382.1986Search in Google Scholar PubMed
6. Fipps DR, Damato JJ, Burke DS. Effects of heat inactivation on HIV antibody screening and confirmation test systems. Diagn Microbiol Infect Dis 1998;10:103–7.10.1016/0732-8893(88)90047-8Search in Google Scholar
7. van den Akker R, Hekker AC, Osterhaus AD. Heat inactivation of serum may interfere with HTLV-III/LAV serology. Lancet 1985;2:672.10.1016/S0140-6736(85)90040-6Search in Google Scholar PubMed
8. Dias D, Van Doren J, Schlottmann S, Kelly S, Puchalski D, Ruiz W, et al. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diagn Lab Immunol 2005;12:959–69.10.1128/CDLI.12.8.959-969.2005Search in Google Scholar PubMed PubMed Central
9. Murat JB, Dard C, Fricker-Hidalgo H, Dardé ML, Brenier-Pinchart MP, Pelloux H. Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns. Clin Vaccine Immunol 2013;20:1203–12.10.1128/CVI.00089-13Search in Google Scholar PubMed PubMed Central
10. Dard C, Bailly S, Drouet T, Fricker-Hidalgo H, Brenier-Pinchart MP, Pelloux H. Long-term sera storage does not significantly modify the interpretation of toxoplasmosis serologies. J Microbiol Methods 2017;134:38–45.10.1016/j.mimet.2017.01.003Search in Google Scholar PubMed
11. Jacobson RH. Validation of serological assays for diagnosis of infectious diseases. Rev Sci Tech 1998;17:469–526.10.20506/rst.17.2.1119Search in Google Scholar PubMed
12. Muratsugu M. Mechanism of aggregates generated by heating human serum. Biol Pharm Bull 1996;19:132–5.10.1248/bpb.19.132Search in Google Scholar PubMed
©2017 Walter de Gruyter GmbH, Berlin/Boston
